eCommons

 

Panel Discussion/ Q&A: Plants as new sources of medicinals: Production of protein pharmaceuticals in food and non-food plants

Other Titles

Abstract

Regulation of transgenic organisms should not be based on the process used to produce them but rather than on the host and the added trait. Highly activist and more moderate public-interest organizations and the regulatory system and associated costs have debilitated public-sector agricultural biotechnology. There is concern over the possibility of adulteration of food if PMPs are produced in crops such as corn, soy and canola. The Grocery Manufacturers of America has asked for a safety evaluation of the implications if PMP-producing food crops are commingled in the food supply; reasonable standards are needed.

Journal / Series

Volume & Issue

Description

Sponsorship

Date Issued

2005

Publisher

NABC

Keywords

Agricultural biotechnology; environment, human health; GMO, genetic engineering, pharming; plant based vaccines; medicinals; regulation; liability, patents; stewardship

Location

Effective Date

Expiration Date

Sector

Employer

Union

Union Local

NAICS

Number of Workers

Committee Chair

Committee Co-Chair

Committee Member

Degree Discipline

Degree Name

Degree Level

Related Version

Related DOI

Related To

Related Part

Based on Related Item

Has Other Format(s)

Part of Related Item

Related To

Related Publication(s)

Link(s) to Related Publication(s)

References

Link(s) to Reference(s)

Previously Published As

Government Document

ISBN

ISMN

ISSN

Other Identifiers

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

Types

book chapter

Accessibility Feature

Accessibility Hazard

Accessibility Summary

Link(s) to Catalog Record